Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × WW Domain-Containing Oxidoreductase × 1 year × Clear all

Sponsor

Conditions

Solid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Head and Neck Fibrosis 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 13 Prednisone 10 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 9 Doxorubicin 9 Vincristine 8 Gemcitabine 5 Azacitidine 5 romidepsin 4 fludarabine 4 Etoposide 4 Dexamethasone 4 Brentuximab Vedotin 4 belinostat 3 Biopsy 3 10-propargyl-10-deazaaminopterin 3 tazemetostat 2 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Bendamustine Hydrochloride 2 venetoclax 1 tislelizumab 1 tipifarnib 1 thymoglobulin 1 sodium-iodide symporter 1 sintilimab 1 selinexor 1 relatlimab 1 pomalidomide 1 parsaclisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡